IGM Biosciences Inc

NASDAQ:IGMS   3:59:52 PM EDT
17.47
+0.70 (+4.17%)
Earnings Announcements

IGM Biosciences Announces Q4 Results

Published: 03/29/2022 10:35 GMT
IGM Biosciences Inc (IGMS) - Cash and Investments As of December 31, 2021 Were $229.5 Million, Compared to $366.3 Million As of December 31, 2020.
Qtrly Loss per Share $1.50.
Expects Full Year GAAP Operating Expenses of $250 Million to $260 Million.
Q4 Earnings per Share View $-1.54 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $51.88 Million
Adjusted EPS is expected to be -$0.56

Next Quarter Revenue Guidance is expected to be $2.26 Million
Next Quarter EPS Guidance is expected to be -$1.41

More details on our Analysts Page.